Janssen-Cilag Polskasp. z o.o.Active
Advertising agencies
KRS: 0000143626 NIP: 5222665719 REGON: 01529633900000
Overview
Registry date
2002-12-17
Share capital
$6,766,612.64
Activity description
Janssen-Cilag Polska is a pharmaceutical company that focuses on innovative medicine, particularly in oncology, immunology, and neuroscience. It has developed and received FDA approval for several treatments, including RYBREVANT FASPRO™ for EGFR-mutated non-small cell lung cancer, CAPLYTA® for major depressive disorder, and DARZALEX FASPRO® for high-risk smoldering multiple myeloma. The company also acquired Halda Therapeutics to enhance cancer treatment options.
Registered address
Iłżecka 24, 02-135 Warszawa, Poland
Website
janssen.plWebsite active
Electronic delivery address
AE:PL-98422-76133-RIAIU-27
Accounts
Registered as a VAT taxpayer on 2003-10-31.Active
- 76 1030 1508 0000 0008 1088 7079
- 51 1030 1508 0000 0008 1088 7044
- 48 1030 1508 0000 0008 1088 7001
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Smollansp. z o.o. | $31,314,517.86 | pmi.pl | |
| Domodisp. z o.o. | $12,618,800.86 | domodi.pl | |
| Unique Onesp. z o.o. | $10,199,051.53 | uniqueone.pl | |
| Webtalksp. z o.o. | $9,626,664.43 | webtalk.pl/ | |
| Blueranksp. z o.o. | $9,076,272.51 | bluerank.pl | |
| Feelgoodsp. z o.o. | $8,945,125.90 | feelgood.pl | |
| Fantasyexposp. z o.o. | $8,746,133.20 | fantasyexpo.pl | |
| Nairobiasp. z o.o. | $8,380,325.13 | nairobia.pl | |
| Bedigitalsp. z o.o. | $8,128,445.76 | bedigital.pl | |
| Goldenberry Groupsp. z o.o. | $7,080,064.68 | goldenberry.com.pl |
Change history
| Event | Details | Date | |
|---|---|---|---|
| Name change | J-c Polska → Janssen-Cilag Polska | 2025-12-16 | |
| PKD change | Removed: 72.30.Z, 73.10.F, 74.13.Z, 74.14.A, 74.40.Z, 74.84.B | 2025-12-16 |
FAQ
Last updated: 2026-07-09